(Q43883837)

27 November 2017

title

PIK3CA mutations and loss of ARID1A protein expression are early events in the development of cystic ovarian clear cell adenocarcinoma (English)

1 reference

27 November 2017

1 reference

2

Hitoshi Tsuda

1 reference

27 November 2017

3

Masashi Takano

1 reference

27 November 2017

5

Osamu Matsubara

1 reference

27 November 2017

Sohei Yamamoto

1

1 reference

27 November 2017

Seiichi Tamai

series ordinal

4

1 reference

27 November 2017

publication date

26 November 2011

1 reference

27 November 2017

1 reference

27 November 2017

volume

460

1 reference

27 November 2017

issue

1

1 reference

27 November 2017

page(s)

77-87

1 reference

Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancers

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1169-8

Long-term follow-up and prognostic factor analysis in clear cell adenocarcinoma of the ovary

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1169-8

Clear cell carcinoma of the ovary: a retrospective multicentre experience of 254 patients with complete surgical staging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1169-8

Frequent activating mutations of PIK3CA in ovarian clear cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1169-8

PIK3CA mutation is an early event in the development of endometriosis-associated ovarian clear cell adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1169-8

ARID1A mutations in endometriosis-associated ovarian carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1169-8

Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1169-8

Dual role of phosphatidylinositol-3,4,5-trisphosphate in the activation of protein kinase B

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1169-8

PIK3CA is implicated as an oncogene in ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1169-8

High frequency of mutations of the PIK3CA gene in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1169-8

Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1169-8

Mutations of PIK3CA in Anaplastic Oligodendrogliomas, High-Grade Astrocytomas, and Medulloblastomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1169-8

PIK3CA gene is frequently mutated in breast carcinomas and hepatocellular carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1169-8

The prevalence of PIK3CA mutations in gastric and colon cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1169-8

PIK3CA mutation is associated with poor prognosis among patients with curatively resected colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1169-8

PIK3CA mutations in colorectal cancer are associated with clinical resistance to EGFR-targeted monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1169-8

Breast cancer-associated PIK3CA mutations are oncogenic in mammary epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1169-8

The SWI/SNF complex and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1169-8

Purification and characterization of mSin3A-containing Brg1 and hBrm chromatin remodeling complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1169-8

Diversity and specialization of mammalian SWI/SNF complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1169-8

Chromatin remodelling during development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1169-8

Clinicopathological significance of loss of ARID1A immunoreactivity in ovarian clear cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1169-8

Cumulative alterations of p27-related cell-cycle regulators in the development of endometriosis-associated ovarian clear cell adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1169-8

Alternate mucoid and hyalinized stroma in clear cell carcinoma of the ovary: manifestation of serial stromal remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1169-8

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1169-8

Mutation and loss of expression of ARID1A in uterine low-grade endometrioid carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1169-8

Cystic and adenofibromatous clear cell carcinomas of the ovary: distinctive tumors that differ in their pathogenesis and behavior: a clinicopathologic analysis of 122 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1169-8

Clear cell adenocarcinoma associated with clear cell adenofibromatous components: a subgroup of ovarian clear cell adenocarcinoma with distinct clinicopathologic characteristics

21 January 2018

1 reference

12 December 2020

Clear-cell adenofibroma can be a clonal precursor for clear-cell adenocarcinoma of the ovary: a possible alternative ovarian clear-cell carcinogenic pathway

1 reference

12 December 2020

PIK3CA and PTEN mutations in uterine endometrioid carcinoma and complex atypical hyperplasia

1 reference

12 December 2020

Expression of platelet-derived growth factors and their receptors in ovarian clear-cell carcinoma and its putative precursors

1 reference

12 December 2020

Loss of ARID1A protein expression occurs as an early event in ovarian clear-cell carcinoma development and frequently coexists with PIK3CA mutations.

1 reference

12 December 2020

10.1007/S00428-011-1169-8

Identifiers

DOI

1 reference

Dimensions Publication ID

27 November 2017

1040218687

0 references

1 reference